Board Stats

Navidea Biopharmaceuticals, Inc.

Y! IH NAVB EXPRESS NAVB Advanced Due Diligence NAVB Oldtimers Lounge TME Macrophage Therapeutics Tx Potential-McGrath Basic Immune Cell Functions Immune Cells M1 and M2 Basics 2022- Magical Mystery Tour of Macrophges

NAVB / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
40335	Alveolar-AM's (M1/M2) important role in respiratory viral infections--UofWV	GN	moneyonomics		1	9/20/2023 7:49:45 PM

40334	Re: Pre 14-a for Annual Meeting filed--one more attempt to avoid a R/S?--strat	GN	LVoptimist		0	9/18/2023 3:36:15 PM

40333	Re: Pre 14-a for Annual Meeting filed--one more attempt to avoid a R/S?--strat	GN	moneyonomics		0	9/17/2023 10:57:14 PM

40332	Unpacking the Complexities of TAMS in cancer progression-authors UCSD-China	GN	moneyonomics		0	9/17/2023 2:05:49 PM

40331	Re: Advantage Manocept in advancing therapeutic targeting/treatment over mannose only use	GN	moneyonomics		0	9/16/2023 5:05:55 PM

40330	M1/M2 reprogramming in full stride(!!) recognition-EXERCISE modulates CD206-CD86	GN	moneyonomics		1	9/16/2023 4:55:30 PM

40329	Mannose receptor among most admired targets for cancer/anti-infective therapeutics-IN	GN	moneyonomics		2	9/16/2023 4:20:29 PM

40328	Re: Pre 14-a for Annual Meeting filed--one more attempt to avoid a R/S?	GN	strategiclr		1	9/15/2023 6:08:06 PM

40327	Pre 14-a for Annual Meeting filed--one more attempt to avoid a R/S?	GN	moneyonomics		2	9/15/2023 3:47:06 PM

40326	Series I transferable warrants mandatory convertible price adjusted up to $2.10 share	GN	moneyonomics		0	9/14/2023 9:08:48 PM

Go to Msg #

BOARDS Sign In for Filters